Folgen
Florentine Hilbers
Florentine Hilbers
Bestätigte E-Mail-Adresse bei nki.nl
Titel
Zitiert von
Zitiert von
Jahr
70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age
M Piccart, LJ van't Veer, C Poncet, JMNL Cardozo, S Delaloge, JY Pierga, ...
The Lancet Oncology 22 (4), 476-488, 2021
2262021
Rare mutations in XRCC2 increase the risk of breast cancer
DJ Park, F Lesueur, T Nguyen-Dumont, M Pertesi, F Odefrey, F Hammet, ...
The American Journal of Human Genetics 90 (4), 734-739, 2012
2182012
Whole exome sequencing suggests much of non-BRCA1/BRCA2 familial breast cancer is due to moderate and low penetrance susceptibility alleles
FJ Gracia-Aznarez, V Fernandez, G Pita, P Peterlongo, O Dominguez, ...
PloS one 8 (2), e55681, 2013
1312013
FANCM c.5791C>T nonsense mutation (rs144567652) induces exon skipping, affects DNA repair activity and is a familial breast cancer risk factor
P Peterlongo, I Catucci, M Colombo, L Caleca, E Mucaki, M Bogliolo, ...
Human molecular genetics 24 (18), 5345-5355, 2015
1042015
Genomic and transcriptomic analyses of breast cancer primaries and matched metastases in AURORA, the Breast International Group (BIG) molecular screening initiative
P Aftimos, M Oliveira, A Irrthum, D Fumagalli, C Sotiriou, EN Gal-Yam, ...
Cancer discovery 11 (11), 2796-2811, 2021
882021
Pregnancies during and after trastuzumab and/or lapatinib in patients with human epidermal growth factor receptor 2–positive early breast cancer: Analysis from the NeoALTTO …
M Lambertini, S Martel, C Campbell, S Guillaume, FS Hilbers, U Schuehly, ...
Cancer 125 (2), 307-316, 2019
672019
MINDACT: Long-term results of the large prospective trial testing the 70-gene signature MammaPrint as guidance for adjuvant chemotherapy in breast cancer patients
F Cardoso, L van’t Veer, C Poncet, J Lopes Cardozo, S Delaloge, ...
J Clin Oncol 38 (suppl 15), 506, 2020
642020
Rare variants in XRCC2 as breast cancer susceptibility alleles
FS Hilbers, JT Wijnen, N Hoogerbrugge, JC Oosterwijk, MJ Collee, ...
Journal of medical genetics 49 (10), 618-620, 2012
602012
Plasma miRNA levels for predicting therapeutic response to neoadjuvant treatment in HER2-positive breast cancer: Results from the NeoALTTO trial
S Di Cosimo, V Appierto, S Pizzamiglio, P Tiberio, MV Iorio, F Hilbers, ...
Clinical cancer research 25 (13), 3887-3895, 2019
542019
Addition of a 161-SNP polygenic risk score to family history-based risk prediction: impact on clinical management in non-BRCA1/2 breast cancer families
IMM Lakeman, FS Hilbers, M Rodríguez-Girondo, A Lee, MPG Vreeswijk, ...
Journal of medical genetics 56 (9), 581-589, 2019
432019
COMPLEXO: identifying the missing heritability of breast cancer via next generation collaboration
COMPLEXO msouthey@ unimelb. edu. au, MC Southey, DJ Park, ...
Breast Cancer Research 15, 1-2, 2013
432013
The impact of next generation sequencing on the analysis of breast cancer susceptibility: a role for extremely rare genetic variation?
FSM Hilbers, MPG Vreeswijk, CJ van Asperen, P Devilee
Clinical genetics 84 (5), 407-414, 2013
402013
Early modulation of circulating microRNAs levels in HER2-positive breast cancer patients treated with trastuzumab-based neoadjuvant therapy
S Di Cosimo, V Appierto, S Pizzamiglio, M Silvestri, J Baselga, M Piccart, ...
International journal of molecular sciences 21 (4), 1386, 2020
392020
Road map to safe and well-designed de-escalation trials of systemic adjuvant therapy for solid tumors.
MJ Piccart, FS Hilbers, JM Bliss, C Caballero, ES Frank, P Renault, ...
AMER SOC CLINICAL ONCOLOGY, 2020
382020
Dissecting the effect of hormone receptor status in patients with HER2-positive early breast cancer: exploratory analysis from the ALTTO (BIG 2-06) randomized clinical trial
M Lambertini, C Campbell, RD Gelber, G Viale, A McCullough, F Hilbers, ...
Breast cancer research and treatment 177, 103-114, 2019
382019
Genetic variants in TGFβ-1 and PAI-1 as possible risk factors for cardiovascular disease after radiotherapy for breast cancer
FSM Hilbers, NB Boekel, AJ van den Broek, R van Hien, S Cornelissen, ...
Radiotherapy and Oncology 102 (1), 115-121, 2012
312012
Exome sequencing of germline DNA from non-BRCA1/2 familial breast cancer cases selected on the basis of aCGH tumor profiling
FS Hilbers, CM Meijers, JFJ Laros, M van Galen, N Hoogerbrugge, ...
PloS one 8 (1), e55734, 2013
302013
Long-term cardiac outcomes of patients with HER2-positive breast cancer treated in the adjuvant lapatinib and/or trastuzumab treatment optimization trial
D Eiger, NF Pondé, D Agbor-Tarh, A Moreno-Aspitia, M Piccart, ...
British journal of cancer 122 (10), 1453-1460, 2020
262020
Clinical utility of MammaPrint testing in invasive lobular carcinoma: results from the MINDACT phase III trial
O Metzger, F Cardoso, C Poncet, C Desmedt, S Linn, J Wesseling, ...
European Journal of Cancer 138, S5-S6, 2020
232020
Breast Cancer Family Registry, Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer, Giles GG, Devilee P, Benitez J, Hopper JL, Tavtigian SV …
DJ Park, F Lesueur, T Nguyen-Dumont, M Pertesi, F Odefrey, F Hammet, ...
Am J Hum Genet 90 (4), 734-9, 2012
232012
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20